Juvenate Health & Wellness - Santa Rosa Beach
2441 U.S. 98 · Santa Rosa Beach, FL 32459
5.0(150 Google reviews · 42 in past year)
Accepts insurance
Listing updated Oct 2, 2026
Coastal Revive
Coastal Revive · 116 Mc Davis Loop · Santa Rosa Beach, FL 32459
5.0· 30 Google reviews
Listing updated October 2, 2026
Retatrutide outlook for this practice
No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.
Care described on the practice's website
- GLP-1 medications named on site
- Medically supervised weight loss
About this practice
Coastal Revive is a telehealth-based wellness practice in Santa Rosa Beach, Florida, that lists weight-loss care with semaglutide and tirzepatide, hormone services and aesthetics. Per its website, the weight-loss process is managed remotely, with a prescription and follow-up to monitor progress and recommendations on diet, exercise and supplements, and it offers injection therapies such as B-12. It carries a 5.0-star Google rating across 30 reviews dating back to 2024, with 11 posted in the past year. Reviewers most often mention results (14 reviews) and the providers' knowledge.
Services & access
| Advertises semaglutide today | Yes |
| Advertises tirzepatide today | Yes |
| Telehealth visits | Yes |
| Cash pay accepted | — |
| Accepts insurance — per practice website | Yes |
| Accepting new patients — per practice website | Yes |
"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.
Review activity
★ 5.0
Google rating · 30 reviews
11
reviews in the past year (avg ★ 5.0)
8
reviews mention weight loss
Counts computed by RetaMaps from public Google reviews; most recent review 2026-09-14. Read the reviews themselves on the practice's Google listing.
What patients say
Rated ★5.0 across 30 Google reviews. Of the 27 reviews we analyzed, 27 (100%) are positive (4–5★) and 0 (0%) are negative (1–2★).
What patients like
- Weight-loss results14 reviews
- Knowledgeable, professional providers9 reviews
- Friendly, helpful staff3 reviews
- Feeling listened to2 reviews
Common complaints
No negative reviews among those we analyzed.
5★
27
4★
0
3★
0
2★
0
1★
0
Most recent Google reviews
Lindsay W.★★★★★2026-09-14Morgan is the best thing since sliced bread! She had been so instrumental in my weight loss journey and is super friendly and easy to talk to about anything and everything that is keeping you held back.
paul h.★★★★★2026-09-14Ms. Morgan is amazing to work with! Would recommend Coastal Revive to anyone on a weight loss journey!
Carrie H.★★★★★2026-05-24I recently had Botox for the first time at 54 years old, and I am so happy with the results. The treatment was quick, comfortable and the results look so natural - refreshed, smoother, and more confident without looking overdone. Morgan at Coastal Revive is the Best! Go see her and you will leave with a more youthful appearance!
Joseph H.★★★★★2026-04-13Mrs Morgan is AMAZING! She has me on a program that is actually working for me. So far I’m down 50 pounds and keeping it going! She is very informative and encouraging. Every time I leave her office I feel like “I can do this!” and keep doing it. If you’ve been struggling with weight loss then you really need to come see her! She’s the best!
Cherish W.★★★★★2026-03-30I received botox and filler. Morgan made me at ease and explained every step in details. She listens to your wants and will give you the best options and what will work best. I am 1000% happy and will definitely come back.
Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.
Nearby providers in Santa Rosa Beach
Retatrutide status
Phase 3 complete · Not FDA-approvedUpdated October 2, 2026
Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.
- Development
- Phase 3 complete
- FDA status
- Submission planned — Q1 2027 (Lilly guidance)
- Availability
- Not commercially available
- Access routes
- Clinical trials, or Lilly's expanded access program (physician must apply)
Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)
Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs